The sponsoring corporate programs are dormant or pivoted
Its extremely short, only basic personal information
GLP-1s are reshaping how we think about systemic inflammation, metabolic health, and skin disease
Common side effects shared by both medications: Nausea (most common, usually transient peaks during dose escalation) Vomiting Diarrhea or constipation Decreased appetite and early satiety Bloating or stomach discomfort Injection site reactions Key safety warnings that apply to both drugs: FDA Boxed Warning (both): Possible risk of thyroid C-cell tumors, based on animal studies
Serious issues can also occur, such as infections or uneven fat removal
We dig into how PCOS and Hashimotos can impact lipid markers through insulin resistance, thyroid hormone conversion, and liver pathways, and why total cholesterol alone is a poor predictor of cardiovascular events